← FDA Drug Approvals (Drugs@FDA)

XDEMVY

NDA · New Drug Application · Sponsor: TARSUS · Approved 2023-07-24

Drug application

FDA Application #

NDA217603

Application type

New Drug Application

Brand name

XDEMVY

Generic name

LOTILANER OPHTHALMIC SOLUTION

Active ingredients

LOTILANER

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

TARSUS

Manufacturer

Tarsus Pharmaceuticals, Inc.

First approval

2023-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown